August 14, 2013 Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
August 6, 2013 Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive, Lewis Barrett, Appointed Senior Vice President, Commercial Strategy of Synthetic Biologics, Inc.
July 18, 2013 Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
June 13, 2013 Synthetic Biologics to Host Multiple Sclerosis-Estriol Investor Day in New York City on June 25, 2013
April 19, 2013 Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
